The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

COLL FINANCIAL STATEMENTS

Collegium Pharmaceutical Inc — balance sheet, income statement and cash flow trends

COLLCollegium Pharmaceutical Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0250 M500 M750 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue808.2 M $Gross Profit485.1 M $ · 60%Operating Income158.5 M $ · 20%Pre-tax Income77.7 M $ · 10%Net Income to Owners47.9 M $ · 6%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue808.2 M $+14.3%
Gross Profit485.1 M $+21.0%
Operating Income158.5 M $+22.2%
EBITDA586.6 M $+69.2%
Net Income to Owners47.9 M $+32.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets2.1 B
  • Equity311.9 M $15%
  • Current Liabilities589.9 M $28%
  • Long-term Liabilities1.2 B $58%

Key Figures

YoY change
Total Assets2.1 B $+34.1%
Total Liabilities1.8 B $+34.1%
Total Equity311.9 M $+34.3%
Cash & ST Investments129.5 M $-41.7%
Total Debt857.8 M $+3.5%
Net Debt728.3 M $+2.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M300 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M0200 M329.9 M $Operating-551.9 M $Investing234.1 M $Financing12.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow329.9 M $+62.1%
Capital Expenditures1.6 M $-2.0%
Free Cash Flow328.3 M $+62.7%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on COLL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.